Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kevin Charles Miller, M.D.

Profile Picture

Mayo Clinic School of Medicine, Rochester, MNMD05/2020Medicine
Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MNMS05/2020Clinical and Translational Science
University of Wisconsin, Madison, WIBS05/2015Genetics

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Miller KC, Johnson PC, Abramson JS, Soumerai JD, Yee AJ, Branagan AR, O'Donnell EK, Saucier A, Jacobson CA, Frigault MJ, Raje NS. Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma. Blood Cancer J. 2022 11 01; 12(10):146. PMID: 36316312; PMCID: PMC9622902.
    Citations:    Fields:    Translation:Humans
  2. Miller KC, Hall AC, Cohen-Bucay A, Chen YB. Delayed kidney transplantation after HLA-haploidentical hematopoietic cell transplantation in a young woman with myelodysplastic syndrome with renal failure. Leuk Res Rep. 2022; 17:100302. PMID: 35360511; PMCID: PMC8961207.
  3. Abdel Rahman ZH, Parrondo RD, Heckman MG, Wieczorek M, Miller KC, Alkhateeb H, Sproat LZ, Murthy H, Hogan WJ, Kharfan-Dabaja MA, Peterson JF, Baughn LB, Hoppman N, Litzow MR, Ketterling RP, Greipp PT, Foran JM. Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemia. Br J Haematol. 2022 02; 196(4):963-968. PMID: 34697797; PMCID: PMC9034764.
    Citations: 1     Fields:    Translation:Humans
  4. Pasvolsky O, Yeshurun M, Fraser R, Estrada-Merly N, Rozovski U, Shargian-Alon L, Assal A, Banerjee R, Bumma N, Gale RP, Hagen P, Holmberg L, Hossain NM, Lazarus HM, Lee C, Mian H, Miller KC, Nathan S, Nagler A, Nishihori T, Parrondo RD, Patel S, Schroeder MA, Usmani SZ, Wang T, Wirk B, Kumar S, Shah N, Qazilbash MH, D'Souza A. Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis. Bone Marrow Transplant. 2022 01; 57(1):31-37. PMID: 34608275; PMCID: PMC8764606.
    Citations: 1     Fields:    Translation:Humans
  5. Abdel Rahman ZH, Miller KC, Jabbour H, Alkhatib Y, Donthireddy V. Outcomes of patients with thrombocytopenia evaluated at hematology subspecialty clinics. Hematol Oncol Stem Cell Ther. 2021 Feb 11. PMID: 33607100.
    Citations:    Fields:    
  6. Miller KC, Chintakuntlawar AV. Molecular-Driven Therapy in Advanced Thyroid Cancer. Curr Treat Options Oncol. 2021 02 10; 22(3):24. PMID: 33569661.
    Citations: 1     Fields:    Translation:Humans
  7. Abdel Rahman ZH, Heckman MG, Miller K, Alkhateeb H, Patnaik MS, Sproat LZ, Jiang L, Roy V, Murthy HS, Ayala E, Hogan WJ, Greipp PT, Kharfan-Dabaja MA, Litzow MR, Foran JM. Impact of Novel Targeted Therapies and Cytogenetic Risk Groups on Outcome After Allogeneic Transplantation for Adult ALL. Transplant Cell Ther. 2021 02; 27(2):165.e1-165.e11. PMID: 33830026.
    Citations: 1     Fields:    Translation:Humans
  8. Miller KC, Abdel Rahman ZH, Robetorye RS, Foran JM. Donor cell-derived chronic myelomonocytic leukemia presenting after allogeneic hematopoietic cell transplantation for T-cell acute lymphoblastic leukemia. Clin Case Rep. 2020 Dec; 8(12):3225-3228. PMID: 33363911.
  9. Bedrose S, Miller KC, Altameemi L, Ali MS, Nassar S, Garg N, Daher M, Eaton KD, Yorio JT, Daniel DB, Campbell M, Bible KC, Ryder M, Chintakuntlawar AV, Habra MA. Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma. J Immunother Cancer. 2020 07; 8(2). PMID: 32737143.
    Citations: 9     Fields:    Translation:Humans
  10. Miller KC, Chintakuntlawar AV, Hilger C, Bancos I, Morris JC, Ryder M, Smith CY, Jenkins SM, Bible KC. Salvage Therapy With Multikinase Inhibitors and Immunotherapy in Advanced Adrenal Cortical Carcinoma. J Endocr Soc. 2020 Jul 01; 4(7):bvaa069. PMID: 32666013; PMCID: PMC7326479.
    Citations: 3     
  11. Miller KC, Marinelli JP, Janus JR, Chintakuntlawar AV, Foote RL, Link MJ, Choby G, Van Gompel JJ. Induction Therapy Prior to Surgical Resection for Patients Presenting with Locally Advanced Esthesioneuroblastoma. J Neurol Surg B Skull Base. 2021 Jul; 82(Suppl 3):e131-e137. PMID: 34306928; PMCID: PMC8289526.
    Citations: 1     
  12. Miller KC, Gertz MA, Buadi FK, Hayman SR, Lacy MQ, Dispenzieri AA, Dingli D, Kapoor P, Gonsalves WI, Kourelis T, Muchtar E, Hogan WJ, Kumar SK. The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myeloma. Bone Marrow Transplant. 2019 12; 54(12):2039-2050. PMID: 31190005.
    Citations: 3     Fields:    Translation:Humans
  13. Ramakrishnan VG, Miller KC, Macon EP, Kimlinger TK, Haug J, Kumar S, Gonsalves WI, Rajkumar SV, Kumar SK. Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma. Haematologica. 2019 10; 104(10):2061-2074. PMID: 30846494.
    Citations: 16     Fields:    Translation:HumansCells
  14. Miller KC, Marinelli JP, Van Gompel JJ, Link MJ, Janus JR, Foote RL, Price KA, Garcia J, Rivera M, Chintakuntlawar AV. Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma. Head Neck. 2019 05; 41(5):1335-1341. PMID: 30536472.
    Citations: 6     Fields:    Translation:Humans
  15. Miller KC, Al-Kali A, Shah MV, Hogan WJ, Elliott MA, Begna KH, Gangat N, Patnaik MM, Viswanatha DS, He R, Greipp PT, Sproat LZ, Foran JM, Litzow MR, Alkhateeb HB. Elderly acute lymphoblastic leukemia: a Mayo Clinic study of 124 patients. Leuk Lymphoma. 2019 04; 60(4):990-999. PMID: 30277111.
    Citations: 5     Fields:    Translation:Humans
  16. Miller KC, Gertz MA, Buadi FK, Hayman SR, Wolf RC, Lacy MQ, Dispenzieri AA, Dingli D, Kapoor P, Gonsalves WI, Kourelis T, Hogan WJ, Kumar SK. Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myeloma. Bone Marrow Transplant. 2019 04; 54(4):587-594. PMID: 30116014; PMCID: PMC6377862.
    Citations: 3     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Miller's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (61)
Co-Authors (10)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.